Barclays PLC I Bio, Inc. Transaction History

Barclays PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.23 - $0.46 $8,068 - $16,137	-35,082 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.3 - $0.61 $68,169 - $138,611	-227,232 Reduced 86.63%	35,082 $16,000
Q4 2021 Feb 14, 2022	BUY	$0.55 - $1.04 $95,697 - $180,955	173,996 Added 197.01%	262,314 $144,000
Q3 2021 Nov 09, 2021	SELL	$1.06 - $1.52 $14,078 - $20,188	-13,282 Reduced 13.07%	88,318 $93,000
Q2 2021 Aug 13, 2021	SELL	$1.22 - $1.65 $184,962 - $250,154	-151,609 Reduced 59.88%	101,600 $153,000
Q1 2021 May 13, 2021	BUY	$1.18 - $2.62 $230,164 - $511,044	195,055 Added 335.41%	253,209 $389,000
Q4 2020 Feb 11, 2021	BUY	$1.05 - $2.24 $257 - $548	245 Added 0.42%	58,154 $61,000
Q3 2020 Nov 12, 2020	BUY	$1.7 - $6.41 $20,318 - $76,612	11,952 Added 26.01%	57,909 $118,000
Q2 2020 Aug 12, 2020	BUY	$0.87 - $2.46 $39,982 - $113,054	45,957 New	45,957 $103,000
Q1 2020 May 13, 2020	SELL	$0.22 - $2.45 $6,609 - $73,600	-30,041 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$0.11 - $0.58 $3,304 - $17,423	30,041 New	30,041 $7,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $23.8M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.